Colorectal Cancer Clinical Trials

Showing 861-880 of 1,434 trials

COMPLETEDPHASE3

Capecitabine in the Perioperative Treatment of Rectal Cancer

NCT01500993

This study compares capecitabine with standard 5-FU in the perioperative treatment of locally advanced rectal cancer.

Rectal Cancer

Universitätsmedizin Mannheim401 participantsStarted Mar 2002

Aschersleben, Germany • Hagen, Germany • Kaiserslautern, Germany +11 more locations

UNKNOWNPHASE2/PHASE3

SGM-101 in Locally Advanced and Recurrent Rectal Cancer

NCT04642924

Near-infrared fluorescence-guided oncologic surgery (EGOS) with the use of a tumor specific tracer (SGM-101) developed by Surgimab can provide valuable intra-operative information about tumor location and extensiveness, which can be difficult to detect with conventional visual and tactile feedback. Hence, this information could aid in intra-operative decision making and therewith foster complete resection margins and less extensive surgery. Subsequently, this may drastically improve patient care by improving oncologic outcome.

Rectal CancerRecurrent Rectal Cancer

Leiden University Medical Center203 participantsStarted Oct 2019

Amsterdam, Netherlands • Eindhoven, Netherlands • Rotterdam, Netherlands +1 more locations

Capecitabine in the Perioperative Treatment of Rectal Cancer

SGM-101 in Locally Advanced and Recurrent Rectal Cancer

Related Searches

Immunophenotyping of Metastases From Colorectal Cancer

Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer

Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Comparison of NOSES and Conventional Laparoscopic Surgery in Colorectal Cancer

Screen to Save: A Colorectal Cancer Educational Intervention

Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Improving Care After Chemotherapy

Early Diagnosis of Oxaliplatin-induced Portal Hypertension

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients

Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma

ColoRectal Cancer in India: catastrOphiC expenDIture and Referral Pathways infLuencE on Presentation and Treatment